Brain stem glioma and Lymphopenia

Summary:

Lymphopenia is found among people with Brain stem glioma, especially for people who are female, 2-9 old.

The study analyzes which people have Lymphopenia with Brain stem glioma. It is created by eHealthMe based on reports of 11 people who have Brain stem glioma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 30, 2022

11 people who have Brain Stem Glioma and Lymphopenia are studied.


What is Brain stem glioma?

Brain stem glioma (cancerous glioma tumour in the brainstem) is found to be associated with 72 drugs and 23 conditions by eHealthMe.

What is Lymphopenia?

Lymphopenia (an abnormally low level of lymphocytes in the blood) is found to be associated with 1,317 drugs and 1,001 conditions by eHealthMe.

Number of Lymphopenia in Brain stem glioma reports submitted per year:

Would you have Lymphopenia when you have Brain stem glioma?

Gender of people who have Brain Stem Glioma and experienced Lymphopenia *:

  • female: 75 %
  • male: 25 %

Age of people who have Brain Stem Glioma and experienced Lymphopenia *:

  • 0-1: 0.0 %
  • 2-9: 71.43 %
  • 10-19: 28.57 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Malignant Glioma (cancerous tumour of brain a cancer tumour of uncertain origin that arises both in soft tissue and bone): 1 person, 9.09%
  2. Intracranial Pressure Increased (high pressure inside the skull and thus in the brain tissue and cerebrospinal fluid): 1 person, 9.09%

Common drugs taken by these people *:

  1. Temozolomide: 4 people, 36.36%
  2. Dexamethasone: 4 people, 36.36%
  3. Temodar: 2 people, 18.18%
  4. Gleevec: 2 people, 18.18%
  5. Decadron: 2 people, 18.18%
  6. Avastin: 2 people, 18.18%
  7. Septra: 1 person, 9.09%
  8. Pegintron: 1 person, 9.09%
  9. Irinotecan Hydrochloride: 1 person, 9.09%

Common symptoms for these people *:

  1. High Blood Pressure: 4 people, 36.36%
  2. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 36.36%
  3. Pancreatitis (inflammation of pancreas): 3 people, 27.27%
  4. Fever: 3 people, 27.27%
  5. Impaired Healing: 3 people, 27.27%
  6. Disease Progression: 3 people, 27.27%
  7. Thrombocytopenia (decrease of platelets in blood): 3 people, 27.27%
  8. Alanine Aminotransferase Increased: 1 person, 9.09%
  9. Bleeding Disorders: 1 person, 9.09%
  10. Cerebral Ventricle Dilatation (enlargement of ventricle of brain): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Lymphopenia?

Check whether Lymphopenia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Lymphopenia:

Common drugs associated with Lymphopenia:

All the drugs that are associated with Lymphopenia:

Common conditions associated with Lymphopenia:

All the conditions that are associated with Lymphopenia:

How the study uses the data?

The study is based on Lymphopenia and Brain stem glioma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: